Psilocybin for methamphetamine use disorder
Part of Mental health clinical trials.
This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a moderate or severe methamphetamine use disorder, scoring at least 4 on a severity scale.
- You must have used methamphetamine on more than 7 of the last 30 days and had at least one positive urine test.
- Your goal must be to completely stop using methamphetamine.
- You need a friend or family member to take you home after the dosing session.
- Your overall health must be good, with no serious mental health conditions (like psychosis or bipolar disorder), and no high blood pressure at rest (above 140/90).
- You must not be taking certain medications that interact with psilocybin, and you must have had no psychedelic use in the past 3 years and limited lifetime use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
This study tests whether a drug called psilocybin (a psychedelic) can help people with HIV stop using methamphetamine. If you want to quit meth and are living with HIV, this trial might offer a new approach.
This study tests whether combining a non-invasive brain stimulation technique (TMS) with a mental exercise called 'episodic future thinking' can help people reduce methamphetamine use. TMS uses magnetic pulses to stimulate brain areas linked to addiction, and episodic future thinking involves imagining positive future events to reduce cravings.
This trial tests whether a single dose of psilocybin (PEX010) combined with therapy can help people stop using methamphetamine or other stimulants. It focuses on safety and early signs of effectiveness.
This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.
This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.